bpc-157 august 2025 study BPC-157: Tendon Repair and More BPC-157 Peptide: Heal Muscles, Joints
Description
A single-arm, prospective study is currently ongoing with apatinib in combination with camrelizumab, etoposide and cisplatin in first-line treatment of ES-SCLC (ClinicalTrial.gov: NCT04490421)
The 10mg vial is ideal for the Phase 1 starting dose
or leaky gut. Its essentially your body lowering the drawbridge
doi: 10.1038/npp.2014.53
